supported by the National Research,Development and Innovation Office of Hungary(NKFI FK 138842,K 131627,FK 134751,K 125174,K 139230,VEKOP-2.3.3-15-2017-00016,and EFOP-3.6.3-VEKOP-16-2017-00009);by TKP2021-EGA-25,by the European Union’s Horizon 2020 Research and Innovation Program under grant agreement number 739593;by a Momentum Research Grant from the Hungarian Academy of Sciences(LP-2021-14 to ZVV);by the Harriet Van Vleet Endowment(to GT).Project number RRF-2.3.1-21-2022-00003 has been implemented with the support provided by the European Union.
Lysophosphatidic acid(LPA)is a bioactive phospholipid mediator that has been found to ameliorate nonsteroidal anti-inflammatory drug(NSAID)-induced gastric injury by acting on lysophosphatidic acid type 2 receptor(LPA...
Supported by the National Natural Science Foundation of China,No.81672465;the Science and Technology Program of Liaoning Province,No.2019JH8/10300080。
The KAI1/CD82 gene inhibits the metastasis of most tumors and is remarkably correlated with tumor invasion and prognosis.Cell metabolism dysregulation is an important cause of tumor occurrence,development,and metastas...
supported by the National 13th 5-Year Plan for Hepatitis Research(No.2017ZX10203201);the National Natural Science Foundation of China(No.81870429).
Background and Aims:Recent accumulating evidence indicates the biological actions of autotaxin(ATX)in liver disease.However,the relationship between ATX and liver failure has not been reported.The present study aimed ...
BACKGROUND Autotaxin(ATX)has been reported as a direct biomarker for estimating the evaluation of liver fibrosis.But available data on ATX as a useful biomarker for the complications of liver cirrhosis(LC)are scant.AI...